We subsequently developed a far more certain probe, [18F]CFA, which was Utilized in the current review to evaluate dCK action in tumors when addressed with a small molecule dCK inhibitor. This probe is also becoming analyzed within a scientific demo at our institution to evaluate modifications in dCK action following cancer immunotherapy 18. PET pr